FDA Looks for Stakeholder Input on Trials Meant to Assess Abuse of Opioids

The FDA has experienced no shortage of criticism in recent years about its regulation of opioid-based painkillers in light of the drugs’ contribution to what the Centers for Disease Control and Prevention calls an “epidemic of prescription painkiller abuse.”
Regulatory Focus